×

Sign In

Search
Home

Cytokinetics’ heart disease drug meets main goal in late-stage study

By Thomson Reuters May 13, 2025 | 6:45 AM

(Reuters) -Cytokinetics said on Tuesday its experimental heart disease drug met the main goal in a late-stage study.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)

Iran's above-ground enrichment plant at Natanz destroyed, IAEA chief says

Iran fires fewer than 100 missiles at Israel; most intercepted, Israeli military says

Investors eye US protests, Iran tensions as S&P 500 stalls

Motor racing-F1 movie could not have been made without Hamilton, says director

Former Florida hedge fund manager charged with insider trading, again

US military helped stop Iranian missiles heading to Israel, officials say

Privacy Policy
Terms Of Service

Copyright © 2025. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.